Colonial Trust’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.6K Hold
65
﹤0.01% 579
2026
Q1
$31.3K Hold
65
﹤0.01% 602
2025
Q4
$36.6K Sell
65
-7
-10% -$3.97K ﹤0.01% 595
2025
Q3
$37.1K Hold
72
0.01% 589
2025
Q2
$22.3K Buy
72
+10
+16% +$3K ﹤0.01% 660
2025
Q1
$18.9K Sell
62
-113
-65% -$38K ﹤0.01% 696
2024
Q4
$58K Buy
175
+105
+150% +$35.6K 0.01% 547
2024
Q3
$23.1K Buy
70
+8
+13% +$3.04K ﹤0.01% 688
2024
Q2
$26.3K Hold
62
﹤0.01% 618
2024
Q1
$25K Hold
62
﹤0.01% 620
2023
Q4
$19.3K Buy
62
+8
+15% +$2.16K ﹤0.01% 636
2023
Q3
$14.7K Buy
54
+18
+50% +$4.6K ﹤0.01% 651
2023
Q2
$8.46K Buy
+36
New +$7.48K ﹤0.01% 725

Other funds holding MEDP

Colonial Trust's MEDP Position: Q2 2026 in Review

Colonial Trust held its Medpace (MEDP) position steady in Q2 2026 at 65 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Colonial Trust first reported a position in MEDP in Q2 2023 and has held it in 13 quarters since. The position peaked at $58K in Q4 2024. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Colonial Trust held 65 shares of Medpace worth $34.6K as of Q2 2026.
  • Colonial Trust left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #579 holding.
  • Colonial Trust first reported a position in Medpace in Q2 2023 and has held it in 13 quarters since.
  • Colonial Trust's Medpace position peaked at $58K in Q4 2024.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.